Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI

NCT07164859 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1700

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease (CAD)
Percutaneous Coronary Intervention (PCI)
Antiplatelet Therapy
Elderly (People Aged 65 or More)

Interventions

DRUG: short dual antiplatelet therapy (DAPT) duration
DRUG: Standard DAPT duration

Sponsor

Vincent ROULE